Summit Technopolis hands over ready plot to Oryx Biotech

Summit Technopolis, a subsidiary of Summit Group, within six months after tripartite agreement signing, handed over the possession of 25 acres of land to Oryx Bio-tech for setting up plasma fractionation plant on Sunday.

Prior to handing over, Summit Technopolis has completed extensive land improvement with additional Tk 5.14 crore investment to meet the critical requirements for the development of the country’s first biotechnology plant, according to a press statement.

This biotech investment in Bangladesh with a valuation of $300 million will be built at the Block II of Bangabandhu Hi-Tech City, Gazipur.

 

Oryx Bio-tech is a subsidiary of Oryx Biotech Holdings based in China and it is expected that about 2,000 high-value science graduates will be employed when the plant is expected to commence operation in 2023, subject to obtaining all the regulatory permissions.

Director of BHTPA ANM Shafiqul Islam, Deputy Director of BHTPA Mahfuzul Kabir and other senior officials were also present at the handover ceremony at the ICT Tower at Agargaon in the capital.

Summit Technopolis Limited, a Public Private Partnership (PPP), is the concessionaire for developing infrastructure for hi-tech industry comprising of Information Technology (IT), Information Technology Enabled Services (ITeS), bio-tech, non-polluting manufacturing assembly lines and precision engineering companies, in the 91 acres area in Bangabandhu Hi- Tech City, Kaliakoir, Gazipur.

Summit Technopolis leased under the provision to design, build, finance, own, operate and transfer to the government on completion of 60 years lease period.

HM

Summit Technopolis hands over ready plot to Oryx Biotech

Summit Technopolis, a subsidiary of Summit Group, within six months after tripartite agreement signing, handed over the possession of 25 acres of land to Oryx Bio-tech for setting up plasma fractionation plant on Sunday. Prior to handing over, Summit Technopolis has completed extensive land improvement with additional Tk 5.14 crore investment to meet the critical requirements for the development of the countrys first biotechnology plant, according to a press statement. This biotech investment in Bangladesh with a valuation of $300 million will be built at the Block II of Bangabandhu Hi-Tech City, Gazipur. Oryx Bio-tech is a subsidiary of Oryx Biotech Holdings based in China and it is expected that about 2,000 high-value science graduates will be employed when the plant is expected to commence operation in 2023, subject to obtaining all the regulatory permissions. Director of BHTPA ANM Shafiqul Islam, Deputy Director of BHTPA Mahfuzul Kabir and other senior officials were also present at the handover ceremony at the ICT Tower at Agargaon in the capital. Summit Technopolis Limited, a Public Private Partnership (PPP), is the concessionaire for developing infrastructure for hi-tech industry comprising of Information Technology (IT), Information Technology Enabled Services (ITeS), bio-tech, non-polluting manufacturing assembly lines and precision engineering companies, in the 91 acres area in Bangabandhu Hi- Tech City, Kaliakoir, Gazipur. Summit Technopolis leased under the provision to design, build, finance, own, operate and transfer to the government on completion of 60 years lease period. HM